Celldex Therapeutics, Inc. (CLDX)

NASDAQ: CLDX · Real-Time Price · USD

38.92

-0.76 (-1.92%)

Sep 8, 2026, 3:14 PM EDT - Market open

Celldex Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,056	1,805	1,677	2,169	2,099	1,803
Market Cap Growth	94.93%	7.65%	-22.71%	3.32%	16.42%	160.10%
Enterprise Value	2,344	1,224	924	1,936	1,779	1,383
Last Close Price	39.68	27.16	25.27	39.66	44.57	38.64

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	19542.92	1168.13	238.82	315.12	890.64	387.68
PB Ratio	4.36	3.42	2.24	5.05	6.44	4.30
P/TBV Ratio	4.49	3.61	2.33	5.40	7.02	4.60

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	15032.27	792.34	131.57	281.34	754.94	297.37

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.01	0.00	0.01	0.01	0.01	0.01
Net Debt / Equity Ratio	-1.00	-0.98	-0.97	-0.98	-0.92	-0.97
Net Debt / EBITDA Ratio	2.21	1.82	3.76	3.03	2.89	6.13
Net Debt / FCF Ratio	2.94	2.42	4.52	3.86	2.85	6.52
Asset Turnover	0	0.00	0.01	0.02	0.01	0.01
Quick Ratio	11.71	10.21	18.38	13.69	16.41	24.71
Current Ratio	11.82	10.49	18.92	13.87	17.07	24.86
Return on Equity (ROE)	-43.88%	-40.62%	-26.84%	-37.45%	-30.13%	-22.43%
Return on Assets (ROA)	-27.62%	-26.12%	-19.38%	-21.70%	-16.79%	-12.70%
Return on Capital Employed (ROCE)	-45.20%	-54.00%	-25.90%	-32.70%	-32.10%	-16.20%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-9.73%	-14.34%	-9.42%	-6.52%	-5.35%	-3.91%
FCF Yield	-7.84%	-11.84%	-9.53%	-5.03%	-5.03%	-3.45%
Buyback Yield / Dilution	-4.49%	-3.15%	-32.91%	-3.33%	-9.37%	-44.64%

SEC Filings: 10-K · 10-Q